Related Experiment Videos
Protein kinase A type I: a target for cancer therapy
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Adjuvant immunotherapy in high-risk stage II melanoma: real-world outcomes from a large multicenter retrospective study.
Cancer immunology, immunotherapy : CII·2026
Complete and Persistent Response to Immunotherapy in Highly Pretreated MSS TMB-High Pancreatic Adenocarcinoma: A Case Report and Literature Review.
International journal of molecular sciences·2026
Is Airway Stent a Definitive Treatment for Management of Malignant Central Airway Obstruction?
Annals of thoracic surgery short reports·2026
Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
EMB-01, an Anti-EGFR/c-MET Bispecific Antibody, in Patients with Heavily Pretreated Metastatic Colorectal Cancer From a Phase Ib/II, Open-Label, Multicenter Study.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Ultrasensitive circulating tumor DNA analysis improves detection of molecular residual disease in locally advanced esophageal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Danvatirsen plus pembrolizumab versus pembrolizumab for recurrent and/or metastatic head and neck squamous cell carcinoma (PEMDA-HN): a randomized, phase 2 trial.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Efficacy of actinium-225-labeled fully human anti-MUC-16 radioimmunoconjugate against MUC-16-positive ovarian and pancreatic ductal adenocarcinoma xenograft models.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026